Comprehensive Urinary Tract Infection (UTI) qPCR Panel

Comprehensive Urinary Tract Infection (UTI) qPCR Panel 

Urinary tract infections (UTIs) are some of the most frequently diagnosed infections, impacting any part of the urinary system—including the kidneys, ureters, bladder, and urethra. Most UTIs affect the lower urinary tract, specifically the bladder and urethra. 

Who is at Risk? 

- Women: Over 50% will experience at least one UTI in their lifetime; 20–30% of these women may face a recurrence within 6 months. 

- Men: Less common in younger men, but rates rise significantly after age 50 due to prostate-related issues. 

- Older Adults: UTIs are a leading cause of sepsis and hospitalization in elderly individuals, especially those in nursing homes. 

- Children: Up to 8% of girls and 2% of boys will have had a UTI by age 7. 

In the U.S., UTIs account for approximately 10 million physician visits and 1 million ER visits each year. 

What Makes Our UTI Panel Different? 

This qPCR-based panel is the most comprehensive on the market, capable of identifying: 

- 44 pathogens: including bacteria, viruses, fungi, and protozoa 

- 43 antibiotic resistance (ABR) genes 

Molecular diagnostics deliver fast, accurate results—usually within 24 hours of sample receipt—providing a more reliable and efficient alternative to traditional urine cultures. 

Why Choose Molecular UTI Testing? 

✅ High Sensitivity & Specificity — Accurately detects pathogens often missed by culture methods 

✅ Rapid Results — Results typically delivered within 24 hours 

✅ Antibiotic Resistance Detection — Identifies resistance genes to support targeted therapy 

✅ Ideal for Difficult Cases — Effective in identifying slow-growing or difficult-to-culture organisms 

Molecular UTI testing is especially beneficial when conventional cultures are inconclusive, time-consuming, or fail to identify the causative agent. 

Detected Pathogens